ArticleClinical and translational medicine2025

Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II study.

Xiaowei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.